"In the justified worries about drug resistance, it tends to get somewhat lost that there is, as yet, no completely untreatable superbug," BioWorld's Senior Science Editor Anette Breindl clarified in part I (June 21, 2016) of our series. Staff Writer Nuala Moran examined the varied factors that led us to this point in time. We also provided some intellectual property (IP) insights and shared a Disease Briefing on multidrug-resistant bacterial infections from Cortellis Competitive Intelligence.